164 related articles for article (PubMed ID: 6245710)
21. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.
Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE
Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of the cyclic nucleotide phosphodiesterases of normal and leukemic lymphocytes.
Hait WN; Weiss B
Biochim Biophys Acta; 1977 Mar; 497(1):86-100. PubMed ID: 14711
[TBL] [Abstract][Full Text] [Related]
23. Cyclic 3':5'-adenosine monophosphate phosphodiesterase and cyclic 3':5'-guanosine monophosphate phosphodiesterase of normal granulocytes and granulocytes of chronic myelogenous leukaemia.
UciĆski WS; Naskalski JW
Haematologia (Budap); 1986; 19(4):275-83. PubMed ID: 3028916
[TBL] [Abstract][Full Text] [Related]
24. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
Hidaka H; Asano T
Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
[TBL] [Abstract][Full Text] [Related]
25. RMI 12330A, an inhibitor of cyclic nucleotide phosphodiesterases and adenylate cyclase in kidney preparations.
Hunt NH; Evans T
Biochim Biophys Acta; 1980 Jun; 613(2):499-506. PubMed ID: 6256001
[TBL] [Abstract][Full Text] [Related]
26. Serum cyclic 3',5'-nucleotide phosphodiesterase activity in myocardial infarction.
Nagasaka A; Nishijima K; Hidaka H; Tanaka T; Yoshida S; Nakai A; Ohyama T; Mizuno Y
Acta Cardiol; 1985; 40(6):613-20. PubMed ID: 3006409
[TBL] [Abstract][Full Text] [Related]
27. Effect of diamide and reduced glutathione on the elevated levels of cyclic AMP in rat pancreatic islets exposed to glucose, p-chloromercuribenzoate and aminophylline.
Ammon HP; Heinzl S; Abdel-Hamid M; Kallenberger HM; Hagenloh I
Naunyn Schmiedebergs Arch Pharmacol; 1982 Jun; 319(3):243-8. PubMed ID: 6287310
[TBL] [Abstract][Full Text] [Related]
28. Cyclic AMP phosphodiesterase in human lymphocytes and lymphoblasts.
Takemoto DJ; Lee WN; Kaplan SA; Appleman MM
J Cyclic Nucleotide Res; 1978 Apr; 4(2):123-32. PubMed ID: 207751
[TBL] [Abstract][Full Text] [Related]
29. Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction.
Frossard N; Landry Y; Pauli G; Ruckstuhl M
Br J Pharmacol; 1981 Aug; 73(4):933-8. PubMed ID: 6168323
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of human lymphocyte cyclic nucleotide phosphodiesterases by the chlorinated adenosine analog DTA-35.
Hurwitz MY; Hurwitz RL; Edstrom RD
J Enzyme Inhib; 1987; 1(4):267-74. PubMed ID: 2854846
[TBL] [Abstract][Full Text] [Related]
31. Mepacrine-induced inhibition of human platelet cyclic-GMP phosphodiesterase.
Yamakado T; Tanaka F; Hidaka H
Biochim Biophys Acta; 1984 Sep; 801(1):111-6. PubMed ID: 6147162
[TBL] [Abstract][Full Text] [Related]
32. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
Donnelly TE; Barron B
Biochim Biophys Acta; 1981 Jan; 657(1):168-78. PubMed ID: 6260197
[TBL] [Abstract][Full Text] [Related]
33. Effects of diamide on cyclic nucleotide levels in rat retina.
Winkler BS; Fletcher RT; Chader GJ
Invest Ophthalmol Vis Sci; 1984 Apr; 25(4):461-3. PubMed ID: 6323342
[TBL] [Abstract][Full Text] [Related]
34. Antiplatelet effects of KW-7, a new inhibitor of cyclic nucleotide phosphodiesterases.
Wu CC; Wang WY; Kuo RY; Chang FR; Wu YC
Eur J Pharmacol; 2004 Jan; 483(2-3):187-94. PubMed ID: 14729106
[TBL] [Abstract][Full Text] [Related]
35. Papaverine and Ro 20-1724 inhibit cyclic nucleotide phosphodiesterase activity and increase cyclic AMP levels in psoriatic epidermis in vitro.
Rusin LJ; Duell EA; Voorhees JJ
J Invest Dermatol; 1978 Aug; 71(2):154-6. PubMed ID: 210235
[TBL] [Abstract][Full Text] [Related]
36. Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase.
Strada SJ; Epstein PM; Gardner EA; Thompson WJ; Stancel GM
Biochim Biophys Acta; 1981 Sep; 661(1):12-20. PubMed ID: 6271215
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
Ilien B; Ruckstuhl M; Landry Y
J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
[TBL] [Abstract][Full Text] [Related]
38. Hydrolysis of guanosine and adenosine 3',5'-monophosphates by rat blood.
Patterson WD; Hardman JG; Sutherland EW
Biochim Biophys Acta; 1975 Mar; 384(1):159-67. PubMed ID: 165831
[TBL] [Abstract][Full Text] [Related]
39. Selective inhibition of rat lung cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase by cyclic nucleotides and their analogues and various drugs [proceedings].
Butt NM; Saeed SA; Collier HO
Biochem Soc Trans; 1980 Jun; 8(3):380-1. PubMed ID: 6249674
[No Abstract] [Full Text] [Related]
40. Protein activator of cyclic AMP phosphodiesterase and cyclic nucleotide phosphodiesterase in bovine retina and bovine lens. Activity, subcellular distribution and kinetic parameters.
Liu YP; Schwartz HS
Biochim Biophys Acta; 1978 Sep; 526(1):186-93. PubMed ID: 210826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]